Back

New-onset heart failure after catheter ablation of atrial fibrillation in patients without a history of heart failure

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation 2 Clinical HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Yasuhiro Yoshiga

Yamaguchi University Graduate School of Medicine, Ube (Japan)

5 More presentations in this session

Presentation thumbnail
A model of atrial fibrillation in dogs with chronic heart failure
Doctor G. Singh (Bakersfield, US)
Abstract Slides Video
Presentation thumbnail
Characterising the role of atrial fibrillation in heart failure with preserved ejection fraction
Doctor S. Ng (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Particularities of foundational therapy in patients with newly diagnosed heart failure and reduced LVEF secondary to tachycardiomyopathy.
Doctor A. Esteban Fernandez (Leganes, ES)
Abstract Slides Video
Presentation thumbnail
Catheter ablation for atrial fibrillation in patients with clinical heart failure: real-world experience from a tertiary centre
Doctor A. Aguiar Neves (Vila Nova de Gaia, PT)
Abstract Slides Video
Presentation thumbnail
Incidence of atrial fibrillation detected by an insertable cardiac monitor in patients with symptomatic heart failure with reduced and preserved ejection fraction.
Mr S. Sarkar (Moundsview, US)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation 2

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
The contemporary guideline-directed medical therapy (GDMT) for heart failure is associated with a reduced incidence of new-onset atrial fibrillation in the elderly patients
thumbnail
Congress Presentation
Catheter ablation for atrial fibrillation in patients with clinical heart failure: real-world experience from a tertiary centre
thumbnail
Congress Presentation
Effects of atrial fibrillation ablation in patients with heart failure: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources